ViviCells International, Inc.
VCII
Other OTC0.00
USD
- -
- -
ViviCells International, Inc.
VCII
(Other OTC)
Recent
price
0.00
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- ViviCells International, Inc. (VCII) operates as a stem cell preservation company in the healthcare sector. The company provides stem cell collection, processing, cryopreservation, and storage services; it focuses on preserving hematopoietic stem cells from umbilical cord blood for potential therapeutic use in treating degenerative diseases and supporting regenerative medicine applications. Incorporated in 1995 and headquartered at 2142 Ashland Avenue, Suite 2, Evanston, Illinois, United States, ViviCells targets families and healthcare providers primarily in the U.S. market with its biotechnology solutions. Previously known as Tropical Beverage Inc., the company changed its name to ViviCells International, Inc. in May 2008 to reflect its pivot to stem cell preservation activities. Recent financial data indicates trailing twelve-month revenue of US$5.09 million as of the last reported period, though no major partnerships, acquisitions, funding rounds, or new product launches have been publicly disclosed within the past 1-2 years; the firm maintains a micro-cap market value of approximately US$23,000 and trades on OTCPK.